Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC.
Reuss JE, Brigham E, Psoter KJ, Voong KR, Shankar B, Ettinger DS, Marrone KA, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Forde PM, Suresh K, Naidoo J. Reuss JE, et al. Among authors: psoter kj. JTO Clin Res Rep. 2021 Aug 26;2(10):100220. doi: 10.1016/j.jtocrr.2021.100220. eCollection 2021 Oct. JTO Clin Res Rep. 2021. PMID: 34746881 Free PMC article.
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J. Suresh K, et al. Among authors: psoter kj. J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26. J Thorac Oncol. 2018. PMID: 30267842 Free article.
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.
Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Naidoo J. Suresh K, et al. Among authors: psoter kj. J Thorac Oncol. 2019 Mar;14(3):494-502. doi: 10.1016/j.jtho.2018.11.016. Epub 2018 Nov 30. J Thorac Oncol. 2019. PMID: 30503891 Free article.
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
Hsu ML, Murray JC, Psoter KJ, Zhang J, Barasa D, Brahmer JR, Ettinger DS, Forde PM, Hann CL, Lam VK, Levy B, Marrone KA, Patel T, Peterson V, Sagorsky S, Turner M, Anagnostou V, Naidoo J, Feliciano JL. Hsu ML, et al. Among authors: psoter kj. Oncologist. 2022 Nov 3;27(11):971-981. doi: 10.1093/oncolo/oyac140. Oncologist. 2022. PMID: 35972337 Free PMC article.
Post hoc survival analyses using RNAseq data: handle with care.
Suresh K, Psoter KJ. Suresh K, et al. Among authors: psoter kj. Am J Physiol Lung Cell Mol Physiol. 2023 Jan 1;324(1):L1-L4. doi: 10.1152/ajplung.00037.2022. Epub 2022 Nov 21. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 36410024 Free PMC article.
Heterogeneity of Lung Function Phenotypes in Sarcoidosis: Role of Race and Sex Differences.
Sharp M, Psoter KJ, Balasubramanian A, Pulapaka AV, Chen ES, Brown SW, Mathai SC, Gilotra NA, Chrispin J, Bascom R, Bernstein R, Eakin MN, Wise RA, Moller DR, McCormack MC. Sharp M, et al. Among authors: psoter kj. Ann Am Thorac Soc. 2023 Jan;20(1):30-37. doi: 10.1513/AnnalsATS.202204-328OC. Ann Am Thorac Soc. 2023. PMID: 35926103 Free PMC article.
81 results